Functional Involvement of Rat Organic Anion Transporter 3 (rOat3;Slc22a8) in the Renal Uptake of Organic Anions
- 1 March 2002
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Journal of Pharmacology and Experimental Therapeutics
- Vol. 300 (3), 746-753
- https://doi.org/10.1124/jpet.300.3.746
Abstract
Our previous kinetic analyses have shown that the transporter responsible for the renal uptake of pravastatin, an HMG-CoA reductase inhibitor, differs from that involved in its hepatic uptake. Although organic anion transporting polypeptides are now known to be responsible for the hepatic uptake of pravastatin, the renal uptake mechanism has not been clarified yet. In the present study, the involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of pravastatin was investigated. Immunohistochemical staining indicates the basolateral localization of rOat3 in the kidney. rOat1- and rOat3-expressed LLC-PK1 cells exhibited specific uptake ofp-aminohippurate (PAH) and pravastatin, respectively, with the Michaelis-Menten constants (Kmvalues) of 60 μM for rOat1-meditad PAH uptake and 13 μM for rOat3-mediated pravastatin uptake. Saturable uptake of PAH and pravastatin was observed in kidney slices withKm values of 69 and 11 μM, respectively. The difference in the potency of PAH and pravastatin in inhibiting uptake by kidney slices suggests that different transporters are responsible for their renal uptake. This was also supported by the difference in the degree of inhibition by benzylpenicillin, a relatively selective inhibitor of rOat3, for the uptake of PAH and pravastatin by kidney slices. These results suggest that rOat1 and rOat3 are mainly responsible for the renal uptake of PAH and pravastatin, respectively.Keywords
This publication has 25 references indexed in Scilit:
- Identification and Characterization of Human Organic Anion Transporter 3 Expressing Predominantly in the KidneyPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2001
- Transport of Drugs Across the Hepatic Sinusoidal Membrane: Sinusoidal Drug Influx and Efflux in the LiverSeminars in Liver Disease, 2000
- Cellular and molecular aspects of drug transport in the kidneyKidney International, 2000
- The multispecific organic anion transporter (OAT) familyPflügers Archiv - European Journal of Physiology, 2000
- Developmental changes in multispecific organic anion transporter 1 expression in the rat kidneyKidney International, 2000
- Excretion of GSSG and Glutathione Conjugates Mediated by MRP1 and CM0AT/MRP2Seminars in Liver Disease, 1998
- Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liverHepatology, 1997
- TISSUE-SELECTIVE UPTAKE OF PRAVASTATIN IN RATS: CONTRIBUTION OF A SPECIFIC CARRIER-MEDIATED UPTAKE SYSTEMBiopharmaceutics & Drug Disposition, 1996
- Disposition of pravastatin sodium, a tissue‐selective HMG‐CoA reductase inhibitor, in healthy subjects.British Journal of Clinical Pharmacology, 1990
- A pharmacokinetic analysis program (multi) for microcomputer.Journal of Pharmacobio-Dynamics, 1981